Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA
Michelle E. Pizzo, Edward D. Plowey, Nathalie Khoury, Wanda Kwan, Jordan Abettan, Sarah L. DeVos, Claire B. Discenza, Timothy Earr, David A. Joy, Ming Lye‐Barthel, Elysia Roche, Darren Chan, Jason C. Dugas, Kapil G. Gadkar, René Meisner, , Y. Joy Yu Zuchero
This study develops an antibody transport vehicle targeting the transferrin receptor to improve brain delivery of anti-amyloid antibodies, reducing ARIA-like lesions and vascular inflammation in a mouse model.
bioRxiv · Jul 26, 2024 · PreprintNeuroscience